683 Capital Management »

Amicus Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.6M 835k 7.88
2025-06-30 $5.5M 960k 5.73
2025-03-31 $2.2M 275k 8.16
2023-12-31 $4.2M 296k 14.19

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Pictet Asset Management Holding SA
Perceptive Advisors
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics